There was a marginally significant difference in overall survival between high and standard risk patients ( P log-rank = 0.035).
← all excerpts
Outcome of refractory and relapsed acute myeloid leukemia in children treated during 2005-2011 - experience of the Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG).
1
—
—